Accolade Stock

accolade.comHealthcare / Other HealthcareFounded: 2007Funding to Date: $240.34MM

Accolade is the provider of a personalized health and benefits solution intended to dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members.

Register To Buy and Sell Shares

For more details on financing and valuation for Accolade, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Accolade’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Accolade.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Accolade investors also invested in these private companies

Team

Management Team

Stephen Barnes
Chief Financial Officer
Mike McGee
Chief Information Security Officer
J. Michael Cline
Co-Founder & Board Member
Rajeev Singh
Chief Executive Officer and Board Member
Robert Cavanaugh
President, Field Operations
Harish Naidu
Chief Technology Officer
Shantanu Nundy MD
Chief Medical Officer

Board Members

Dawn Lepore
John Rowe
Peter Klein
Thomas Neff
Spencer Stuart
Edgar Bronfman Jr.
Jeffrey Jordan
Andreessen Horowitz
Mark Mactas
Charles Patton
Rajeev Singh
James Madden
Carrick Capital Partners
J. Michael Cline
Matthew McIlwain
Madrona Venture Group
Michael Yang
Comcast Ventures
William Frist MD
Carrick Capital Partners

Frequently Asked Questions About Accolade’s Stock

plusminus
Can you buy Accolade’s stock?
Accolade is not publicly traded on NYSE or NASDAQ in the U.S. To buy Accolade’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Accolade’s stock?
Yes, you can sell stock of a private company like Accolade. Forge can help you sell your Accolade stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Accolade’s stock price?
Accolade is a privately held company and therefore does not have a public stock price. However, you may access Accolade’s private market stock price with Forge Data.
plusminus
What is Accolade’s stock ticker symbol?
Accolade does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Accolade Is Latest To Join Health Service IPO Bandwagon
Venture-backed health care service providers follow the IPO trail with successful results.
Mobile Health Benefit Platform Accolade Seeks IPO | PYMNTS.com
Health tech startup Accolade, with headquarters in Seattle and Philadelphia, filed with the Security and Exchange Commission (SEC). 
Tech Moves: Accolade names chief medical officer; Apptio hires marketing lead; Rigado has a new CEO
Tech Moves: Accolade names chief medical officer; Apptio hires marketing lead; Rigado has a new CEO
Updated on: Feb 28, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.